TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 12/3030% below fair value
$1.82−0.03 (-1.62%)
Close on Nov 12, 2026Market cap $21.07MP/E –Yield –
TherapeuticsMD statistics
75 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 12, 2026 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Nov 12, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 0.89
- 2.29
- P/OCF Ratio
- 6.80
- 12.93
Enterprise valuationIndustry
- EV / Sales
- 3.63
- 2.60
Share statisticsIndustry
- Shares Change (YoY)
- 0.44%
- 10.9%
- Shares Change (QoQ)
- 0.00%
- 0.48%
- Float
- 11M
- 49M
- Shares Held by Insiders
- 1.56%
- 12.1%
- Shares Held by Institutions
- 31.7%
- 56.4%
Short sellingIndustry
- Short Interest
- 31,319
- –
- Short Interest Change
- 27.0%
- -0.76%
- Short % of Float
- 0.27%
- 9.06%
- Short % of Shares Outstanding
- 0.27%
- 6.30%
- Days to Cover
- 1.47
- 5.13
Stock price statisticsIndustry
- 52-Week High
- $2.95
- –
- 52-Week Low
- $1.43
- –
- 20-Day Moving Average
- $1.81
- –
- 50-Day Moving Average
- $1.98
- –
- 200-Day Moving Average
- $2.09
- –
- Average True Range (14)
- $0.08
- –
- Price Change (1 Week)
- 6.43%
- 1.51%
- Price Change (1 Month)
- -7.61%
- -2.37%
- Price Change (3 Months)
- -12.1%
- -21.1%
- Price Change (6 Months)
- -8.54%
- -22.8%
- Price Change (YTD)
- 11.7%
- -22.6%
- Price Change (1 Year)
- 11.3%
- -21.0%
- Price Change (3 Years)
- -9.68%
- -24.8%
- Price Change (5 Years)
- -94.2%
- -76.9%
- Price Change (10 Years)
- -99.4%
- -63.2%
- Average Volume (10 Days)
- 15,184
- –
- Average Volume (20 Days)
- 19,291
- –
- Average Volume (90 Days)
- 22,368
- –
- Relative Volume
- 0.22
- 0.80
- Relative Strength Index (14)
- 46.9
- 44.7
- Volatility (1 Year)
- 69.2%
- 80.2%
- Beta (5 Years)
- 0.66
- 1.07
MarginsIndustry
- Pretax Margin
- -8.04%
- -11.8%
- EBITDA Margin
- -109.2%
- -27.7%
Returns on capitalIndustry
- Return on Equity (ROE)
- -0.80%
- -51.3%
- Return on Assets (ROA)
- -0.57%
- -40.7%
- Return on Invested Capital (ROIC)
- -15.9%
- -32.9%
- Return on Capital Employed (ROCE)
- -12.2%
- -38.1%
Financial positionIndustry
- Current Ratio
- 3.22
- 3.31
- Quick Ratio
- 1.84
- 2.41
GrowthIndustry
- Revenue Growth (YoY)
- 27.8%
- 7.26%
- Revenue Growth (3Y CAGR)
- -64.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- -45.8%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.09
- 0.40
- Revenue Per Employee
- $3.27M
- $429.38K
- Profits Per Employee
- -$217.00K
- -$683.67K
- Employee Count
- 1
- 75
- WACC
- 8.16%
- 10.0%
Income statement (TTM)Industry
- Pretax Income
- -$263.00K
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $9.19M
- $16.98M
- Net Cash Per Share
- $0.79
- $0.72
- Equity (Book Value)
- $27.13M
- $52.68M
- Book Value Per Share
- $2.34
- $1.50
- Tangible Book Value
- $23.57M
- $26.74M
- Working Capital
- $11.12M
- $78.52M
Cash flow (TTM)Industry
Dividends and yieldsIndustry
- Earnings Yield
- -1.03%
- -21.0%
Scores and fair valueIndustry
- Altman Z-Score
- -34.21
- 0.26
- Piotroski F-Score
- 6
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | TXMD | S&P 500 | Difference | TXMD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -9.9% | -2.7% | −7.2 pts | ||
| 3 months | -12.5% | -1.7% | −10.8 pts | ||
| Year to date | +11.7% | +11.9% | −0.2 pts | ||
| 1 year | +8.3% | +12.0% | −3.7 pts | ||
| 3 years | -9.0% | +78.2% | −87.2 pts | -3.1% | +21.2% |
| 5 years | -94.2% | +73.2% | −167.5 pts | -43.4% | +11.6% |
| 10 years | -99.4% | +309.6% | −409.1 pts | -40.5% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M TXMD shares were sold short on Oct 30, 2026, up 27.0% from the previous report, or 0.27% of the shares available to trade. At recent volumes it would take 1.5 days to buy them back. Over the last 20 sessions, 39.3% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 31,319 | +27.0% | 21,273 | 1.5 |
| Oct 15, 2026 | 24,664 | +4.2% | 17,330 | 1.4 |
| Sep 30, 2026 | 23,663 | -10.5% | 17,014 | 1.4 |
| Sep 15, 2026 | 26,437 | +0.2% | 20,859 | 1.3 |
| Aug 31, 2026 | 26,387 | -4.5% | 46,926 | 1.0 |
| Aug 14, 2026 | 27,618 | -5.2% | 14,982 | 1.8 |
| Jul 31, 2026 | 29,141 | -32.5% | 21,417 | 1.4 |
| Jul 15, 2026 | 43,171 | -23.7% | 27,388 | 1.6 |
| Jun 30, 2026 | 56,548 | +22.5% | 36,355 | 1.6 |
| Jun 15, 2026 | 46,148 | -10.2% | 100,011 | 1.0 |
| May 29, 2026 | 51,412 | -3.1% | 15,712 | 3.3 |
| May 15, 2026 | 53,083 | -6.5% | 22,738 | 2.3 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?